Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic
Authors:
- Peter M. GeorgePGPeter M. George
- Stephen T. ChambersSCStephen T. Chambers
- 1 January 2005
- journal article
- Published by Elsevier in Metabolism
- Vol. 54 (1) , 1-14
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseasesAtherosclerosis, 1999
- Meta-analysis of Hyperhomocysteinemia as a Risk Factor for Venous Thromboembolic DiseaseArchives of internal medicine (1960), 1998
- Human Betaine–Homocysteine Methyltransferase Is a Zinc MetalloenzymeArchives of Biochemistry and Biophysics, 1998
- Folate Deficiencies and Cardiovascular PathologiesClinical Chemistry and Laboratory Medicine (CCLM), 1998
- Low Circulating Folate and Vitamin B 6 ConcentrationsCirculation, 1998
- Human Homocysteine Catabolism: Three Major Pathways and Their Relevance to Development of Arterial Occlusive DiseaseThe Journal of Nutrition, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolismMetabolism, 1993
- Hyperhomocyst(e)inemia as a Risk Factor for Occlusive Vascular DiseaseAnnual Review of Nutrition, 1992
- Homocysteinemia due to folate deficiencyMetabolism, 1987